Clinical Trial – Genetics of Congenital Heart Disease – Congenital Heart Disease

Nationwide children’s hospital is now recruiting volunteers to participate in a clinical trial for congenital heart disease, called genetics of congenital heart disease. Congenital heart disease is the most common type of birth defect, but the etiology of it remains unknown. Genetic causes have been discovered for both syndromic and non-syndromic CHD utilizing several genetic approaches. One method that can be utilized to identify genetic causes of CHD is screening of large populations of children with sporadic cases of CHD for genetic abnormalities. We want to recruit 1,000 participants who are family-based to take part in this trial. The final object is to identify novel genetic contributors to congenital heart defects. We hope to identify genetic contributors associated with congenital heart defects in humans.

The treatment is blood sample collection. No drugs.

Study Type : Observational
Estimated Enrollment : 1000 participants
Observational Model: Family-Based
Time Perspective: Prospective
Official Title: Genetics Testing of Individuals and Families With Congenital Heart Disease
Study Start Date : December 2009
Estimated Primary Completion Date : December 2025
Estimated Study Completion Date : December 2025

Contact information:

Locations

United States, Ohio
Nationwide Children’s Hospital Recruiting
Columbus, Ohio, United States, 43205
Principal Investigator: Vidu Garg, MD
Contact: Vidu Garg, MD 614-355-5740 vidu.garg@nationwidechildrens.org
* The Content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.